[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts.

INTRODUCTION: APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti-tumor effect in several pre-clinical tumor models and is currently in several clinical phase II studies. 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) is a tracer used to ass...

Description complète

Détails bibliographiques

Auteurs principaux:	Mette Munk Jensen, Kamille Dumong Erichsen, Camilla Bardram Johnbeck, Fredrik Björkling, Jacob Madsen, Michael Bzorek, Peter Buhl Jensen, Liselotte Højgaard, Maxwell Sehested, Andreas Kjær
Format:	Artigo
Langue:	Inglês
Publié:	Public Library of Science (PLoS) 2013-01-01
Collection:	PLoS ONE
Accès en ligne:	http://europepmc.org/articles/PMC3537726?pdf=render
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!